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ABSTRACT
Objective: To examine how leading clinical journals
report research ﬁndings, aiming to assess how they
frame their implications for medical practice and to
compare that literature’s patterns with those of the
management literature.
Data Source: Clinically relevant research articles from
three leading clinical journals (N Engl J Med, JAMA,
and Ann Intern Med).
Methods: Review of wording of a sequential sample
from 2010, with categorisation, comparison among
journals, and comparison with management literature.
Results: Clinical journals usually state that one
approach did or did not differ from another approach
(35 of 51 articles, 68.6%), but they recommended
a speciﬁc course of action (‘therefore, x should be
done’) in just 25.5%. One article gave instruction on
how to implement the changes. Two-thirds of the
reports called for further research. Half used tentative
language. Management research articles nearly always
speciﬁed who should use the information and drew
from over 60 types of potential users, whereas the
clinical literature named the audience in only 23.5% of
clinicians.
Conclusions: Authors and editors of the clinical
literature could test being more clear and direct in
presenting implications of research ﬁndings for
practice, including stating when the ﬁndings do not
justify changes in practice.
INTRODUCTION
In March 2010, Bartunek and Rynes
1
reviewed the leading professional literature
in organisational management, showing that
a minority of papers provide concrete and
clear advice arising from the research and
that most used tentative language in
conveying their advice. We were curious as to
the patterns and practices in the medical
literature.
Clarke and Chalmers
2 in 1998 reviewed 26
randomised clinical trials and found only two
articles that deliberately integrated their new
ﬁndings into existing literature. Lewis
3
suggested that passive voice and unclear
comments limited the usefulness of articles
to healthcare decision makers. Lucas
4
conﬁrmed that medical journals usually give
tentative result statements. Tunis and
colleagues
5 reported that clinical trial
research regularly fails to give decision
makers enough information to make well-
informed decisions, perhaps because investi-
gators have little incentive to reach out to
practising clinicians or policy makers.
This paper examines recent research
reports in leading medical journals to gain
insight into how authors interpret the
implications of their ﬁndings for medical
practice.
METHODS
Journal and article selection
Since we were seeking to characterise broadly
inﬂuential journals, we selected those with
the highest ‘Journal Impact Factor (JIF)’,
which tallies the citations of articles in one
journal in all professional journals.
6 The top
three US medical journals by (2004e2009)
JIF score are The New England Journal of
Medicine (NEJM), The Journal of the American
Medical Association (JAMA) and Annals of
Internal Medicine (Annals). The subscribers
are mostly clinicians; for example, JAMA
reports 100% of their circulation goes to
physicians, medical students, hospitals and
ﬁrms associated with the medical profession.
7
Two authors (APO and JL) reviewed the
table of contents for each issue of each
journal, starting with the ﬁrst edition of 2010,
until we had identiﬁed more than 20 articles
with titles that appeared to report primary
research relevant to the medical care of
human beings, excluding reviews, editorials
and other items.
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The social determinants of actionReview of selected articles
Each author independently reviewed each article. We
excluded articles that did not report ﬁndings relevant to
medical treatment (because they reported basic science,
epidemiological description or methodological work).
Our reviews focused upon identifying statements that
articulated implications for practice in the Abstract or
Discussion sections. In addition, we identiﬁed statements
that the ﬁndings had implications for future research or
for public health. We did not code guidelines or medical
advice that did not arise from the current research.
Annals publishes a short comment from the Editor,
which we discuss separately.
After initial review, we developed categories to code
and all three authors independently reviewed each
article, identiﬁed the appropriate text and coded it. We
resolved any coding disagreements by discussion. The
Bartunek and Rynes article
1 identiﬁed that managers
prefer straightforward, clearly implementable prescrip-
tions for practice.
8 Thus, we examined the text that
articulated implications for practice, being careful to
identify tentative language (eg, words such as ‘may’,
‘speculate’, and ‘potentially’). We also tallied prescrip-
tive language, such as ‘ought’ and ‘must’. We tabulated
ﬁndings that applied to a subset of situations, which we
called ‘contingencies’. Finally, we coded whether the
article identiﬁed who (eg, the physician), if anyone,
should take account of the ﬁndings.
We then compared the three journals, using overall c
2
tests; and, when appropriate, we compared pairs of
journals using Bonferroni’s correction for signiﬁcance




We tabulated text ﬁndings on Excel and managed
coding and analyses with SPSS (PASW V.18).
RESULTS
The cohort and coding
Aiming to sample $20 articles per journal, we reviewed
NEJM through 28 February 2010; JAMA through 10
March 2010 and Annals through 6 April 2010. The initial
cohort totalled 65 articles, with 21 from NEJM, 21 from
JAMA and 23 from Annals. The initial review excluded
14 articles, leaving a cohort of 51 that reported research
that could be important to medical practice: 18 from
NEJM,
9e26 12 from JAMA
27e38 and 21 from Annals.
39e59
Figure 1 illustrates the derivation of this analytic cohort.
Thirty-ﬁve articles gave advice that ‘X was better than Y
with regard to Z’ or ‘X is no better than Y with regard to
Z’. These statements often hedged: ‘X seemed to be
better than Y’ or ‘X may prove to be better than Y’.
These statements did not intimate what other consider-
ations might affect the practitioner’s decision as to
whether to change. We called these statements ‘Minimal
Advice’, and 28 articles gave only this kind of phrasing.
We identiﬁed four additional patterns for stating the
implications of ﬁndings for practice: ‘practitioner should
consider’ (labelled ‘Consider’); ‘patient should be
informed’ (labelled ‘Inform’); ‘practitioner should do’
(labelled ‘Act’); and ‘practitioner should do and here’s
how’ (labelled ‘Technical Assistance’).
Statements about implications for practice
One article by Ray et al
55 stated factual ﬁndings with no
evaluative statement at all. This article reported results
from a large observational study that assessed two kinds
of medications. The outcomes were complex, showing
competing gains and risks. The information would be
useful for a practitioner to consider, though the article
did not explicitly state that conclusion. The information
could not have yielded advice to prefer one treatment
strategy, except perhaps to inform the patient.
Table 1 shows the number and proportion of the other
50 articles that provided the ﬁve kinds of advice, overall
and for each journal and ﬁgure 2 illustrates the overlap
among the kinds of advice given.
Figure 1 Article cohort derivation.
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The social determinants of actionEleven articles called on someone to ‘consider’ acting
in response to the ﬁndings. In no case did the article
give additional advice as to how that person might weigh
the issues or what other considerations should enter into
the deliberation. For instance, ‘Early resumption of low-
dose aspirin therapy with proton pump inhibitors in
patients with bleeding ulcers and cardiovascular disease
should be considered’.
39
Two articles called for informing the patient as part of
the implementation of ﬁndings, one concerning inﬂu-
enza immunisation
11 and one concerning feeding tube
placement.
29 For example, ‘As the current pandemic
unfolds, pregnant and postpartum women should be
counseled about the importance of vaccination’.
11
Thirteen articles called for speciﬁc action, generally
stating ‘The physician should.’. For example, ‘Our
ﬁndings also suggest that compression ultrasonography
might be considered for patients with symptomatic SVT
at presentation to evaluate the extent of the thrombosis
and diagnose potential DVT, that physicians should
suspect and test for pulmonary embolism in patients
with suggestive symptoms.’.
50 The ﬁrst clause counts as
a ‘Consider’ statement; the second as an ‘Act’ statement.
One article provided a unique approach. Goldstein
et al
54 published a ‘Brief Communication’ in Annals that
gave research ﬁndings and stated clear directives for
action and also provided an on-line appendix with
details about implementation.
Often, the authors appear to assume that the reader
would know the implications for practice and do not
state them. Van der Gaag et al,
16 for example, found that
‘Routine perioperative biliary drainage in patients
undergoing surgery for cancer of the pancreatic head
increases the rate of complications’. However, the article
does not state the obvious implication for practice: do
not do the drainage procedure in this setting.
Additional attributes of statements about implications
of the research
We describe various attributes of how the articles provide
implications for practice in table 2.
Two-thirds (66.7%) of the articles called for future
research, usually using a broad and brief formulation. For
example, Goebel et al
45 claimed: ‘Additional studies are
needed to determine which patients are likely to beneﬁt
and which IVIG doses and schedules are most effective’.
In 9.8% of the cases, the articles stated an implication for
public health actions such as developing guidelines or
including certain services in funding. Nachega et al,
41 for
example, called for monitoring adherence to anti-retro-
viral therapy to be part of ‘the package of care in anti-
retroviral therapy programs in all settings’, which would
require action by funders and governments.
Forty-seven per cent of the articles used tentative
language in stating their implications for practice. For
example, ‘Our ﬁndings suggest that the use of morphine
during trauma care may reduce the risk of subsequent
development of PTSD after serious injury’.
14 As in this
example, many used two or more tentative terms.
Sometimes, the writing strongly avoided being direct,
for example, ‘Therefore, we believe that prescribing an













NEJM (n¼18) 16 (88.9) 4 (22.2) 1 (5.6) 1 (5.6) 0
JAMA (n¼12) 10 (83.3) 1 (8.3) 1 (1.9) 2 (16.7) 0
Annals (n¼21) 9 (42.9) 6 (28.6) 0 10 (47.6) 1 (4.8)
Total* (N¼51) 35 (68.6) 11 (21.6) 2 (3.9) 13 (25.5) 1 (2.0)
*Totals sum to >100% because categories are not mutually exclusive.
Figure 2 Number of articles by category.
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The social determinants of actionNSAID to treat an asymptomatic postoperative pericar-
dial effusion should no longer be advised’.
47 The reader
might reasonably wonder whether this is a matter of faith
that requires belief and also who should no longer be
advising whom.
About 39% of the articles had some prescriptive
language. For example, ‘Until then, clinical practice
should not be guided by (point-of-care) platelet function
testing’.
31 Contingent (subset) statements were present
in about 29%. For example, ‘In short, most women
contemplating estrogen plus progestin therapy for the
relief of menopausal symptoms should not expect
protection against CHD’.
49
Each journal’s website makes a general statement about
intended readers: NEJM targets ‘medical researchers’,
JAMA claims ‘physician readers’ and Annals focuses on
‘practising physicians’. The stated audience does not
include non-medical professionals, laypersons or patients.
Perhaps this strong assumption about the readership
explains why only 23.5% of the articles specify the people
whose actions should reﬂect the reported ﬁndings.
Authors did specify physicians in 10% of articles and
healthcare providers or clinicians in 8%.
Differences among journals
We analysed the data in tables 1 and 2 for differences
among journals and only two comparisons met conven-
tional standards for signiﬁcance: Annals was signiﬁcantly
less likely to publish ‘Minimal Advice’ than NEJM
(c
2¼8.925, df¼2, p¼0.006). Conversely, Annals was
signiﬁcantly more likely than NEJM to recommend
action (c
2¼8.469, df¼2, p¼0.005).
In Annals, the Editors’ note provides a very short
summary of ﬁndings and cautions. Sometimes, as in
Meurin et al,
47 the Editors give a stronger recommen-
dation than the authors did: ‘Physicians should stop
prescribing NSAIDS for postoperative pericardial effu-
sion because these agents have no or only small beneﬁ-
cial effects’ by the Editors and ‘In patients with
pericardial effusion after cardiac surgery, diclofenac
neither reduced the size of the effusions nor prevented
late cardiac tamponade’ by the authors. On the other
hand, sometimes the Editors’ comments worded the
authors’ conclusions more tentatively than the authors,
as in Schaer et al,
43 where the Editors said ‘In hyper-
tensive patients, mechanisms other than lowering blood
pressure may be important causes of atrial ﬁbrillation’,
while the authors claimed ‘In hypertensive patients,
long-term receipt of ACE inhibitors, ARBs, or beta-
blockers reduces the risk for atrial ﬁbrillation compared
with receipt of calcium-channel blockers’.
Comparison with management research reporting
Management researchers advocating changes in practice
virtually always stated their claims in the active voice. In
contrast, in 33% of cases medical journals used passive
voice, for example, ‘New strategies to reduce the risk
of transmission of HIV-1 are needed for HIV-1e
serodiscordant couples’.
26 Implications for practice
sections in the management literature used tentative
language signiﬁcantly more (74%) than the medical
literature (47%), (c
2¼17.48, df¼1, p<0.001). The
management literature (55%) was also signiﬁcantly
more likely to use prescriptive language than the
medical literature (39%), (c
2¼4.59, df¼1, p¼0.04).
However, contingent advice was similar in frequency in
the management (38%) and medical (29%) literature.
DISCUSSION
This project examined how three inﬂuential US medical
journals present implications of research ﬁndings for
practice. Most research reports provide a summary of the
ﬁndings with a ﬂat descriptive statement that a clinical
outcome is better or worse with the tested intervention
(68.6%). The one article that did not give this level of
advice had ﬁndings that would not support doing so.
Only about one-forth (25.5%) of the reports gave explicit
recommendations for action and only one article
provided instruction as to how to implement the recom-
mended actions. The language in about half of the arti-
cles was tentative (47.1%) and a general call for further
research was common (66.7%). Reporting in the three
journals wasgenerally similar, but as agroup they differed
from the management journals in including fewer calls to
undertake action, and in not specifying who should act.
In this project we studied only a small sample of arti-
cles in a conﬁned time frame, which limited the study’s




















NEJM (n¼18) 10 (55.6) 4 (22.2) 8 (44.4) 3 (16.7) 4 (22.2) 2 (11.1)
JAMA (n¼12) 11 (91.7) 0 6 (50.0) 3 (25.0) 4 (33.3) 2 (16.7)
Annals (n¼21) 13 (61.9) 1 (4.8) 10 (47.6) 9 (42.9) 12 (57.1) 8 (38.1)
Total (N¼51) 34 (66.7) 5 (9.8) 24 (47.1) 15 (29.4) 20 (39.2) 12 (23.5)
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The social determinants of actionpower and generalisability. Furthermore, our review did
not examine editorials or journal review services, which
often serve to put the ﬁndings of single studies into
a broad context and provide substantial advice to the
practitioner as to how to interpret the results.
While the target for implications for practice in
medical journals was either not named or was speciﬁed
only as ‘physicians’ or ‘clinicians’, the management
journals virtually always named the target audience.
Bartunek and Rynes identiﬁed more than 60 categories
of individuals or groups to whom articles addressed their
implications.
1 The clinician audience for these medical
journals may be so obvious as to need no speciﬁcation.
The project raised some intriguing questions as to
optimal reporting. In the management literature assess-
ment, the authors advocated more statements of
the implications for practice
1; in contrast, many of the
articles we sampled from clinical literature had meth-
odological limitations that precluded strong statements
guiding practitioners towards changed practices. The
ﬁndings could often have needed replication or could
need to be weighed along with other considerations in
making individual treatment decisions. Strong state-
ments about medical practice might more often be
justiﬁed in systematic reviews, or clinical practice
guidelines based on extensive literature reviews. One
well-known example is the US Preventive Services
Task Force, which provides authoritative reviews and
grades both the strength of the evidence and of their
recommendations.
60 61
However, clarity in assessing and reporting the impact
of new ﬁndings is desirable, even when the report should
have limited impact. Authors can clearly state what their
work has added to the body of evidence and what its
implications for practice are, even if the clearly stated
advice would often be that a reasonable practitioner
should not change anything yet. This proposal would
operationalise for all research reports the contention of
Clarke and Chalmers
2 regarding randomised clinical
trials. They advocated that each report should state, in
the ‘discussion’ section, how the new ﬁndings reshape
the prior body of evidence concerning the topic.
Editors should also consider undertaking formal tests
of whether authors can clearly and succinctly state
implications for practice, perhaps by providing explicit
guidelines on grades of evidence and levels of recom-
mendation and whether such explicit and consistent
reporting helps readers. If past research and the new
data support a strong recommendation for imple-
mentation, then the article should explicitly state the
major counter-considerations or contingencies and
often can provide ‘technical assistance’ for imple-
mentation. If the authors hold that the ﬁndings are not
yet reliable enough for action, they could state that
judgement clearly, along with their opinion regarding
who should undertake what research or other actions.
Medical research generally builds in small increments
and few articles make a dramatic difference to what
practitioners should do. However, our ﬁndings suggest
that the current system for reporting the implications of
single clinical studies deserves serious re-examination by
authors, editors and readers. Stating the strength of
evidence and recommendations for action in those
studies as directly, unambiguously and consistently as
possible seems to us likely to prove helpful in translating
their results into the most appropriate actions.
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